Bangladesh

South Asia

Contents

1. Regulatory Overview
2. Regulatory Pathways

Regulatory Overview

Bangladesh is regulated by the DGDA (Directorate General of Drug Administration). The country has 1 documented regulatory pathway for accessing unapproved or unlicensed medicines, covering named patient programs, compassionate use schemes, and special access arrangements.

Regulatory Authority

DGDA (Directorate General of Drug Administration)

Regulatory Pathways (1)

DGDA Import Permit for Unregistered Drugs – Bangladesh 45 days

Directorate General of Drug Administration Bangladesh import permit for unregistered medicines needed by patients with serious medical conditions.

Application Form: DGDA Import Permit Form

Legal Basis: Drugs Act 1940 (Bangladesh)

Eligibility: Serious or life-threatening condition with no locally registered alternative

Reference: DGDA Drug Import Guidelines

Bangladesh

ISO Code	`BD`
Region	South Asia
Regulatory Authority	DGDA (Directorate General of Drug Administration)
Pathways	1 documented
Drugs Available	0 documented